This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of thyroid gland
CD2_BENIGN_THYROID_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasma benignum glandulae thyreoideae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of thyroid gland
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of thyroid gland
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1213 | 936 | 277 |
| Unadjusted period prevalence (%) | 0.27 | 0.32 | 0.12 |
| Median age at first event (years) | 51.45 | 49.43 | 58.29 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1088
- Matched controls
- 10879
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
99.2
323.0
477
85
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
9204.7
323.0
883
*
2260A
ICD-9 Finland
Benign neoplasm of thyroid gland[NEOPLASMA BENIGNUM GLANDULAE THYREOIDEAE]
+∞
214.9
199
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
81.6
204.0
227
35
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
124.4
117
*
H03AA01
ATC
levothyroxine sodium; systemic
4.6
114.7
554
1991
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
101.7
96
*
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
20.6
92.7
141
78
2504
FHL
Unilateral resection or enucleation
44.4
90.7
112
28
EP1AE
NOMESCO Finland
Neck ultrasound examination
11.0
90.4
181
193
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
27.0
88.3
123
51
115
Kela drug reimbursment
Breast cancer
+∞
81.3
77
*
104
Kela drug reimbursment
Thyroid insufficiency
5.9
78.8
247
518
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
8.5
75.8
176
241
BAA60
NOMESCO Finland
Total thyroidectomy
13.0
63.3
115
98
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
12.0
60.4
114
105
PJA12
NOMESCO Finland
Sentinel node biopsy
598.6
58.2
57
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
19.8
57.7
88
48
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
55.7
53
*
A04AA02
ATC
granisetron; systemic, transdermal
196.5
54.5
56
*
130
Kela drug reimbursment
Malignant tumour
+∞
53.6
51
*
H02AB02
ATC
dexamethasone; systemic
16.4
52.0
85
56
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
44.0
42
*
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
24.3
43.6
62
27
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
422.9
41.4
41
*
HAC20
NOMESCO Finland
Total mastectomy
218.1
41.2
42
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
40.9
39
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
68.4
40.4
46
7
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
39.8
38
*
L02BA01
ATC
tamoxifen; oral
101.0
35.9
39
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
11.6
35.6
67
61
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
67.3
34.2
39
6
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
347.5
34.1
34
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
336.8
33.1
33
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
32.4
31
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
31.4
30
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
31.4
30
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
31.3
211
820
HAB40
NOMESCO Finland
Wedge excision of mammary gland
22.3
29.8
43
20
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
29.3
28
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
28.2
27
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
27.2
26
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
143.5
26.7
28
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
9.9
26.7
54
57
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
26.1
25
*
L02BG04
ATC
letrozole; oral
15.5
25.7
42
28
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
19.6
25.3
38
20
WZC30
NOMESCO Finland
Teaching
3.3
25.2
139
464
XX3DW
NOMESCO Finland
Time consuming IT work
4.5
25.2
94
226
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
25.1
24
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
25.1
24
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
25.1
24
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.2
24.8
80
165
HA1AA
NOMESCO Finland
X-ray mammography
4.9
23.7
80
174
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
24.3
23.6
33
14
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
23.0
22
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
5.3
22.5
70
139
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
22.1
288
1563
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
21.9
21
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
21.9
21
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
21.1
315
1804
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
20.9
20
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
20.9
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.9
20
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
20.8
234
1184
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
213.8
20.6
21
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.7
20.6
53
83
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
20.1
190
883
WF002
NOMESCO Finland
Radical radiotherapy
36.5
19.9
25
7
JN4AD
NOMESCO Finland
Body CT examination
5.2
19.9
63
128
L01BC06
ATC
capecitabine; oral
+∞
19.8
19
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
19.8
19
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
74.9
19.7
22
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
9.8
19.5
39
41
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.8
19.3
65
141
116
Kela drug reimbursment
Prostate cancer
+∞
18.8
18
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
17.8
17
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
17.8
17
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
17.8
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
17.8
17
*
BAA30
NOMESCO Finland
Excision of thyroid isthmus
182.8
17.6
18
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
17.5
386
2515
A04AA01
ATC
ondansetron; systemic, rectal
5.0
17.5
57
120
WX402
NOMESCO Finland
General anaesthesia
2.4
16.8
162
753
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
16.7
16
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
16.7
16
*
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
16.7
16
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
16.7
16
*
2506
FHL
Thyroidectomy
172.5
16.5
17
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
60.9
15.8
18
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
162.2
15.5
16
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.9
15.2
30
31
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
14.6
14
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
19.4
14.3
21
11
JN4BD
NOMESCO Finland
Extensive body CT
3.2
13.6
71
229
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
13.6
13
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
13.6
13
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
13.6
13
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
13.6
13
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
13.6
13
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.4
13.1
28
34
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.7
12.6
14
*
X76
ICPC
Malignant neoplasm breast female
70.7
12.6
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
27.0
12.1
16
6
S18
ICPC
Laceration/cut
1.6
11.9
402
2890
L03AA02
ATC
filgrastim; parenteral
47.2
11.9
14
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.9
11.8
21
18
N02BE01
ATC
paracetamol; systemic, rectal
1.8
11.8
917
8161
106
Kela drug reimbursment
Hypoparathyroidism
30.4
11.7
15
5
L02BG03
ATC
anastrozole; oral
65.6
11.6
13
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
65.6
11.6
13
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
11.6
234
1452
4CJ01
NOMESCO Finland
NA
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.5
11
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
11.5
11
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
121.2
11.4
12
*
A04AD12
ATC
aprepitant; systemic
121.2
11.4
12
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
11.3
74
279
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
43.8
10.9
13
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
10.9
43
112
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.8
10.5
67
250
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
111.0
10.4
11
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
10.4
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.4
10
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
10.4
10
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
10.4
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.4
10
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
10.4
10
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
10.4
10
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
9.7
10.3
20
21
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.9
10.2
63
229
E83.51
ICD-10 Finland
Hypocalcemia
13.3
10.2
17
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.4
10.0
29
55
JN4CD
NOMESCO Finland
Very extensive body CT
5.1
9.9
30
60
A11CC03
ATC
alfacalcidol; systemic
5.0
9.8
30
61
ZX114
NOMESCO Finland
Intramuscular
5.6
9.7
27
49
ZX090
NOMESCO Finland
Other technic of radiotherapy
55.5
9.7
11
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
9.6
118
611
T86
ICPC
Hypothyroidism/myxoedema
2.8
9.5
61
228
NK6AN
NOMESCO Finland
Total body bone isotope imaging
15.2
9.5
15
10
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
17.7
9.4
14
8
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.2
9.4
48
155
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
9.4
9
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
9.4
9
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
9.4
9
*
L02BG06
ATC
exemestane; oral
+∞
9.4
9
*
T71
ICPC
Malignant neoplasm thyroid
+∞
9.4
9
*
UJF32
NOMESCO Finland
Coloscopy
1.6
9.3
260
1756
UKC02
NOMESCO Finland
Cystoscopy
1.9
9.3
137
760
ZZR00
NOMESCO Finland
Flap of skin
13.8
9.2
15
11
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
15.7
9.0
14
9
ZXA00
NOMESCO Finland
Right side
1.6
9.0
272
1872
SPAT1153
SPAT
Removal of sutures
1.6
9.0
319
2289
A02BC05
ATC
esomeprazole; systemic
1.5
8.9
427
3281
L02AE02
ATC
leuprorelin; implant, parenteral
6.9
8.9
21
31
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
8.8
73
315
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
9.6
8.8
17
18
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
16.4
8.6
13
8
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
27.7
8.5
11
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
20.2
8.5
12
6
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
90.7
8.4
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
90.7
8.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
90.7
8.4
9
*
E03
ICD-10 Finland
Other hypothyroidism
2.2
8.4
86
413
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
12.9
8.4
14
11
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
8.3
8
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
8.3
8
*
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
+∞
8.3
8
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.3
8
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
8.3
8
*
XKD00
NOMESCO Finland
Uroflowmetry
2.0
8.1
99
511
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
7.9
391
3004
Z51.5
ICD-10 Finland
Palliative care
4.4
7.9
27
63
UDC00
NOMESCO Finland
Ear microscopy
2.2
7.7
76
358
R13
ICD-10 Finland
Dysphagia
2.2
7.6
75
351
T72
ICPC
Benign neoplasm thyroid
11.9
7.6
13
11
Y77
ICPC
Malignant neoplasm prostate
80.6
7.4
8
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
80.6
7.4
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
7.3
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
7.3
7
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
7.3
7
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
+∞
7.3
7
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.7
7.3
139
840
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
15.9
7.2
11
7
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
7.2
289
2113
S77
ICPC
Malignant neoplasm of skin
30.2
7.2
9
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
20.2
7.1
10
5
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
12.1
7.1
12
10
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.9
80
406
Z00.0
ICD-10 Finland
General medical examination
1.6
6.9
185
1230
RD211
NOMESCO Finland
NA
2.4
6.8
52
219
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.3
6.8
57
251
JN6AD
NOMESCO Finland
CT of torso and neck
16.8
6.7
10
6
R01AD09
ATC
mometasone; nasal
1.4
6.6
458
3715
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
6.2
6.5
16
26
J02AC01
ATC
fluconazole; systemic
1.4
6.5
439
3545
L02BB03
ATC
bicalutamide; oral
70.2
6.4
7
*
HAD20
NOMESCO Finland
Liposuction of breast
70.2
6.4
7
*
ZX112
NOMESCO Finland
Subcutaneous
8.2
6.3
13
16
E07.9
ICD-10 Finland
Disorder of thyroid, unspecified
11.1
6.3
11
10
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
TQW20
NOMESCO Finland
Tatoe
+∞
6.3
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
+∞
6.3
6
*
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.3
6
*
D44
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of endocrine glands
+∞
6.3
6
*
HAE99
NOMESCO Finland
Other reconstruction of breast
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
26.8
6.2
8
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
26.8
6.2
8
*
ZZA50
NOMESCO Finland
Full thickness skin graft
26.8
6.2
8
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.2
351
2737
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
6.1
74
383
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
12.6
6.1
10
8
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
12.6
6.1
10
8
EP1AE
SPAT
NA
4.4
6.1
20
46
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
131
50
29.25
192.97
6.2
1.1
32.9
45.1
u/ml
0.35
44
15
180
149
14.01
184.79
1.4
1.2
—
—
—
0
0
202
647
3.55
52.37
4.6
3.1
4.4
4.5
pmol/l
0.40
184
554
721
4728
2.29
42.55
7.8
5.1
1.2
1.2
mmol/l
1.74
606
4010
1054
8325
3.03
39.27
7.4
4.2
15.5
14.8
pmol/l
15.66
986
7599
639
4217
2.09
34.22
6.1
4.6
1.2
1.2
mmol/l
2.27
588
3736
599
4241
1.81
22.50
4.3
3.5
—
—
—
0
0
126
496
2.72
22.16
4.4
1.5
14.0
3.3
ug/l
1.15
98
377
474
3144
1.83
21.92
2.8
2.0
2.3
2.4
mmol/l
3.65
409
2643
1113
9730
2.75
21.88
8.5
5.0
1.8
2.0
mu/l
1.26
1041
8916
158
700
2.45
21.78
4.3
2.5
1.2
1.2
mmol/l
1.22
143
582
883
7459
1.68
13.94
8.5
5.3
77.3
74.8
u/l
0.95
836
6901
668
5353
1.55
12.44
9.5
6.5
4.0
4.1
e9/l
0.42
598
4616
591
4614
1.55
12.36
6.9
3.5
11.2
11.0
umol/l
0.10
561
4306
312
2103
1.65
12.20
2.4
2.0
—
—
—
0
0
17
8
21.53
12.02
1.4
1.1
—
—
—
0
0
215
1322
1.76
11.76
2.8
2.3
0.8
0.8
mmol/l
0.08
197
1202
147
806
1.94
11.59
2.9
3.4
67.2
83.2
ng/l
2.30
127
700
888
7685
1.58
10.96
4.6
4.2
12.4
11.7
mm/h
0.67
829
7116
34
94
3.69
10.84
4.1
1.9
156.0
82.8
u/ml
0.27
27
88
557
4414
1.48
10.14
2.5
2.3
79.6
79.2
nmol/l
0.12
507
3915
505
3974
1.46
9.26
4.2
3.5
35.7
36.0
g/l
0.51
459
3647
141
832
1.79
8.78
4.6
3.0
227.1
232.3
u/l
0.35
132
774
673
5645
1.43
8.49
4.5
3.8
6.6
6.7
mmol/l
0.84
645
5221
30
96
3.18
7.72
2.0
3.4
1.8
1.2
%
0.20
17
72
118
687
1.79
7.68
2.2
2.0
0.2
0.2
g/l
1.34
106
634
125
771
1.69
6.65
1.2
1.2
105.1
141.8
iu/ml
0.52
53
307
1113
10517
1.71
6.18
17.1
13.6
139.8
139.8
mmol/l
0.65
1099
10220
60
303
2.03
6.03
2.1
1.8
1.0
1.6
ug/l
0.59
52
263
1114
10546
1.69
5.91
17.3
13.7
3.9
4.0
mmol/l
2.68
1099
10231
140
920
1.59
5.81
3.4
2.9
—
—
—
0
0
10
9
11.19
5.80
2.2
1.7
—
—
—
0
0
1075
10108
1.56
5.65
15.4
11.6
21.1
21.3
mg/l
0.08
867
7734
333
2624
1.37
5.41
4.9
4.0
0.0
0.0
estimate
0.80
142
839
525
4431
1.33
5.39
2.7
2.7
114.8
100.6
ug/l
0.84
476
4092
378
3050
1.35
5.25
2.6
2.2
61.3
58.0
u/l
0.20
342
2808
738
6598
1.30
4.71
5.2
4.5
68.6
2931.3
e6/l
—
5
91
36
170
2.15
4.38
3.4
3.0
4.0
4.1
e9/l
0.11
36
170
36
174
2.10
4.14
3.7
3.2
57.2
57.8
%
0.12
36
174
230
1779
1.36
4.10
2.5
2.2
2.4
2.4
mmol/l
0.44
203
1530
155
1122
1.44
4.07
4.5
4.3
1.0
1.0
mmol/l
0.01
146
1019
11
28
3.96
3.98
2.1
1.6
—
—
—
0
0
446
3800
1.27
3.92
3.8
3.5
29.6
72.7
ng/l
1.02
298
2501
1127
10860
1.53
3.61
11.8
8.8
24.2
24.3
u/l
0.12
1085
10419
185
1425
1.35
3.37
1.8
1.7
—
—
—
0
0
1164
11319
1.70
3.36
23.4
17.5
253.7
256.3
e9/l
0.72
1134
10998
1164
11326
1.69
3.26
23.3
17.5
4.5
4.5
e12/l
0.10
1130
10961
41
228
1.83
3.23
1.6
1.6
—
—
—
0
0
1164
11328
1.68
3.23
23.3
17.5
6.5
6.6
e9/l
0.80
1131
10965
1164
11329
1.68
3.21
23.4
17.6
134.1
134.6
g/l
0.74
1153
11147
443
3843
1.24
3.19
4.7
3.9
—
—
—
0
0
81
542
1.53
3.18
2.4
3.4
5.2
5.2
kpa
0.11
72
504
51
308
1.68
3.05
1.6
1.6
0.2
0.1
iu/ml
0.40
14
60
55
339
1.65
3.05
2.1
1.7
—
—
—
0
0
29
148
1.98
2.96
1.1
1.3
—
—
—
0
0
24
114
2.13
2.95
1.1
1.1
—
—
—
0
0
13
46
2.85
2.92
1.1
1.3
—
—
—
0
0
10
30
3.35
2.91
1.1
1.3
—
—
—
0
0
164
1273
1.33
2.85
2.3
2.3
2.4
2.4
g/l
0.31
150
1177
30
158
1.92
2.82
2.1
2.3
16.7
16.5
%
0.07
14
78
234
1912
1.28
2.78
2.5
2.4
5.1
7.4
e6/l
1.36
201
1661
57
365
1.59
2.74
2.3
1.8
—
—
—
0
0
75
513
1.49
2.70
2.2
3.3
2.3
1.9
mmol/l
0.63
62
379
52
328
1.61
2.67
2.2
2.1
12.5
13.8
nmol/l
0.56
44
291
10
32
3.14
2.65
1.3
1.3
—
—
—
0
0
10
32
3.14
2.65
1.3
1.3
—
—
—
0
0
297
2511
1.24
2.63
2.5
2.2
322.0
5366.4
umol/l
7.19
250
2158
272
2284
1.25
2.56
1.8
1.7
37387829.8
23757049.3
pmol/l
0.14
222
1890
548
4941
1.20
2.52
4.5
3.7
0.0
0.0
estimate
0.00
150
838
679
6243
1.20
2.52
3.0
2.9
—
—
—
0
0
211
1723
1.27
2.52
1.6
1.5
—
—
—
0
0
24
122
1.99
2.51
1.3
1.2
—
—
—
0
0
24
123
1.97
2.46
1.3
1.2
—
—
—
0
0
156
1229
1.31
2.46
27.5
24.4
1.3
1.3
inr
0.06
33
180
24
124
1.95
2.41
1.3
1.2
—
—
—
0
0
5
8
6.27
2.37
1.0
1.1
—
—
—
0
0
1003
9604
1.26
2.36
14.9
10.4
79.6
79.9
ml/min/173m2
0.16
850
7664
35
206
1.72
2.36
2.4
3.2
26.1
25.3
mmol/l
0.64
29
179
119
911
1.34
2.30
2.8
1.8
353.2
365.6
nmol/l
0.28
103
824
549
4981
1.19
2.29
5.7
5.1
0.0
0.0
estimate
0.50
147
841
66
457
1.47
2.27
3.0
2.7
0.2
0.2
e6/l
0.01
66
441
24
127
1.91
2.27
1.3
1.2
—
—
—
0
0
24
127
1.91
2.27
1.3
1.2
—
—
—
0
0
554
5038
1.18
2.23
4.4
3.7
0.0
0.0
estimate
1.08
149
832
24
128
1.89
2.22
1.3
1.2
—
—
—
0
0
273
2328
1.22
2.21
1.2
1.3
0.9
1.7
u/ml
1.37
79
630
42
266
1.60
2.17
1.8
2.0
4382.6
2625.6
u/l
0.19
15
105
234
1969
1.23
2.15
1.3
1.3
30.1
40.2
iu/ml
0.59
84
619
287
2475
1.21
2.07
2.3
2.2
2.9
2.9
mg/l
0.01
239
2092
328
2865
1.20
2.07
1.6
1.6
1.3
1.4
mmol/l
1.65
268
2409
35
215
1.65
2.05
1.3
1.3
—
—
—
0
0
144
1152
1.28
2.05
2.3
2.4
24.4
23.4
%
0.35
115
976
70
505
1.41
1.97
1.7
1.5
—
—
—
0
0
172
1415
1.25
1.95
2.3
2.3
13.8
13.6
umol/l
0.18
161
1298
8
28
2.87
1.86
3.4
4.0
—
—
—
0
0
60
426
1.43
1.86
1.4
1.3
30.6
29.7
iu/l
0.07
55
368
43
286
1.52
1.84
1.8
2.0
2.2
5.3
iu/l
4.03
12
102
79
590
1.36
1.83
1.7
1.6
—
—
—
0
0
5
12
4.18
1.82
1.2
1.1
—
—
—
0
0
23
130
1.78
1.82
1.3
1.4
—
—
—
0
0
26
154
1.70
1.77
1.6
1.2
0.6
0.6
nmol/l
0.01
26
147
18
95
1.91
1.76
5.3
1.9
31.9
32.8
pg
0.48
18
95
10
41
2.45
1.75
1.3
1.3
—
—
—
0
0
10
41
2.45
1.75
1.3
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
209
1.60
1.75
2.1
2.5
0.3
0.4
u/ml
0.29
20
126
8
30
2.68
1.72
1.1
1.3
—
—
—
0
0
7
24
2.93
1.72
3.9
2.2
—
—
—
0
0
0
46
0.00
1.71
0.0
2.2
—
47.3
—
0
35
11
48
2.30
1.70
1.1
1.4
—
—
—
0
0
73
547
1.36
1.68
7.2
6.2
25.0
24.6
mmol/l
0.39
66
514
276
2417
1.18
1.67
1.5
1.5
21.5
21.6
nmol/l
0.03
237
2036
39
261
1.51
1.65
1.3
1.3
—
—
—
0
0
322
2873
1.16
1.55
2.8
2.8
947.4
1233.0
ng/l
0.77
273
2419
160
1343
1.22
1.53
4.7
4.7
33.1
32.9
%
0.06
107
895
348
3126
1.16
1.53
2.0
2.1
147.3
227.2
u/l
1.46
323
2934
25
154
1.64
1.50
1.2
1.4
—
—
—
0
0
683
6433
1.14
1.50
3.2
2.9
47.1
42.2
u/l
0.71
638
5969
148
1237
1.22
1.48
2.4
2.1
105.3
126.4
ug/g
0.60
112
966
16
87
1.85
1.46
1.1
1.3
—
—
—
0
0
118
964
1.25
1.46
3.7
2.6
0.8
0.7
ug/l
0.15
80
628
1043
10141
1.20
1.45
4.8
4.6
5.9
5.9
mmol/l
0.56
942
9244
9
40
2.26
1.40
1.1
1.2
—
—
—
0
0
27
408
0.65
1.39
1.4
1.5
—
—
—
0
0
338
3051
1.15
1.38
3.1
2.5
32.1
30.3
u/l
0.45
313
2908
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
35
240
1.47
1.36
2.9
3.1
—
—
—
0
0
38
265
1.45
1.35
1.2
1.1
—
—
—
0
0
21
128
1.65
1.33
1.9
1.7
—
—
—
0
0
16
90
1.79
1.33
1.1
1.3
—
—
—
0
0
15
83
1.82
1.31
1.2
1.0
—
—
—
0
0
357
3247
1.14
1.30
3.2
3.0
7.0
7.0
mmol/l
0.03
291
2728
5
18
2.78
1.28
1.4
3.3
—
—
—
0
0
97
788
1.25
1.28
8.5
6.2
122.2
121.6
g/l
0.12
92
762
868
8349
1.14
1.27
17.2
13.9
13.6
13.6
%
0.03
855
8135
86
691
1.26
1.25
1.2
1.2
172.1
175.9
u/ml
0.02
79
631
34
237
1.45
1.23
4.7
1.4
1.3
1.4
ratio
—
7
24
23
147
1.58
1.23
1.3
1.4
—
—
—
0
0
15
85
1.77
1.23
1.1
1.1
56.1
53.9
u/l
—
7
60
99
811
1.24
1.23
3.4
3.0
2.6
2.1
mmol/l
0.69
79
655
356
3253
1.13
1.20
4.1
3.9
9.1
8.0
mg/mmol
0.16
192
1928
18
109
1.66
1.19
1.2
1.4
—
—
—
0
0
90
733
1.25
1.18
2.5
1.5
68.5
67.5
g/l
0.73
81
653
12
64
1.88
1.18
1.5
1.9
13.3
19.0
nmol/l
2.11
12
57
56
429
1.32
1.18
2.2
2.1
35.8
39.8
u/l
0.91
51
382
276
2487
1.14
1.15
3.0
2.8
0.4
0.4
e6/l
0.03
210
1840
98
813
1.22
1.10
1.7
1.8
—
—
—
0
0
57
443
1.30
1.10
1.3
1.2
0.3
0.5
u/ml
—
9
36
17
104
1.64
1.09
1.1
1.3
—
—
—
0
0
17
104
1.64
1.09
1.4
1.7
90.7
89.8
%
0.20
17
104
114
962
1.20
1.08
7.9
5.7
12.3
11.9
kpa
0.29
109
924
114
962
1.20
1.08
7.9
5.7
5.1
5.1
kpa
0.09
109
925
117
990
1.20
1.08
1.7
1.7
—
—
—
0
0
17
105
1.63
1.06
1.4
1.3
—
—
—
0
0
12
67
1.80
1.05
1.1
1.4
—
—
—
0
0
34
246
1.39
1.04
4.8
1.4
38.2
41.2
mg/l
0.18
27
207
117
994
1.20
1.04
1.7
1.6
—
—
—
0
0
245
2207
1.14
1.03
2.0
1.6
0.9
1.1
mg/l
0.42
189
1663
34
247
1.39
1.02
4.8
1.4
30.1
56.0
mg/l
0.62
27
207
9
47
1.92
1.02
1.3
1.1
208.3
547.9
u/l
—
9
41
194
1725
1.15
0.99
5.7
3.8
2.2
1.9
ug/l
0.44
168
1537
213
1909
1.14
0.97
1.3
1.3
6.2
14.1
u/ml
1.80
93
743
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
54
1.86
0.96
1.1
1.2
—
—
—
0
0
107
913
1.19
0.93
1.7
2.0
—
—
—
0
0
54
429
1.27
0.91
1.2
1.4
—
—
—
0
0
18
118
1.53
0.91
1.1
1.3
—
—
—
0
0
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
154
1360
1.15
0.88
1.9
1.8
29.0
29.4
s
0.44
147
1307
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
8
44
1.82
0.86
1.3
1.1
—
52.6
%
—
0
5
6
31
1.94
0.84
1.3
1.2
—
—
—
0
0
1050
10306
1.14
0.83
4.5
4.5
4.7
4.7
mmol/l
0.20
953
9552
11
65
1.70
0.82
1.7
1.4
1.0
1.0
g/l
0.06
11
65
35
267
1.32
0.81
1.5
1.4
267.0
320.9
ug/g
0.80
21
153
209
1896
1.12
0.80
3.7
3.7
199.8
414.7
ng/l
1.08
143
1426
1068
10500
1.14
0.80
5.1
5.0
2.8
2.8
mmol/l
0.28
963
9675
5
98
0.51
0.78
1.4
1.3
—
—
—
0
0
110
958
1.16
0.77
8.1
5.7
1.2
1.3
mmol/l
0.11
94
738
1042
10233
1.13
0.77
4.5
4.5
1.5
1.5
mmol/l
0.26
944
9424
63
522
1.22
0.77
1.7
1.6
—
—
—
0
0
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
34
1.77
0.76
1.0
2.4
129.8
127.7
%
—
6
34
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
219
2000
1.12
0.76
1.4
1.4
—
—
—
0
0
10
59
1.70
0.76
1.6
1.4
19440.0
114414.0
e6/l
—
5
34
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
155
1389
1.13
0.74
5.1
3.7
22.6
23.8
%
0.46
85
637
16
108
1.49
0.73
1.8
2.1
16.2
7.0
umol/l
—
9
71
18
125
1.45
0.73
1.2
1.3
106.1
113.4
u/ml
—
7
29
15
218
0.68
0.72
3.2
4.2
27.1
24.7
mg/l
—
6
142
21
152
1.39
0.69
1.1
1.1
—
15.9
—
0
8
7
43
1.63
0.67
1.0
1.1
—
—
—
0
0
13
87
1.50
0.63
1.1
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
38.2
—
0
20
36
290
1.25
0.60
2.1
1.6
322.6
317.9
mu/l
0.04
36
261
18
241
0.74
0.57
1.5
1.5
—
—
—
0
0
20
150
1.34
0.56
1.1
1.1
—
—
—
0
0
19
142
1.34
0.54
1.5
1.6
46.7
62.0
%
0.70
12
90
19
142
1.34
0.54
1.6
1.7
41.6
43.8
nmol/l
0.15
19
136
12
82
1.47
0.54
1.4
1.1
—
—
—
0
0
6
38
1.58
0.54
1.0
1.1
91.7
91.0
%
—
6
33
1002
9867
1.09
0.52
4.0
4.0
1.3
1.3
mmol/l
0.25
898
9003
36
296
1.22
0.52
1.2
1.2
182.7
230.9
miu/ml
0.45
20
141
6
40
1.50
0.51
1.0
1.1
2077.8
1858.9
miu/ml
—
6
40
6
40
1.50
0.51
2.2
2.1
—
—
—
0
0
12
168
0.71
0.50
1.2
1.4
—
—
—
0
0
12
168
0.71
0.50
1.2
1.4
—
—
—
0
0
978
9627
1.08
0.50
5.8
5.9
39.8
39.7
mmol/mol
0.17
889
8923
42
353
1.20
0.49
2.2
1.9
—
—
—
0
0
16
212
0.75
0.49
1.5
1.4
—
—
—
0
0
16
212
0.75
0.49
1.5
1.4
—
—
—
0
0
73
825
0.88
0.48
2.1
2.0
59.4
35.2
u/l
0.55
63
689
16
211
0.76
0.47
1.5
1.4
—
—
—
0
0
16
211
0.76
0.47
1.5
1.4
—
—
—
0
0
46
537
0.85
0.47
1.3
1.3
—
—
—
0
0
30
245
1.23
0.47
1.2
1.2
—
—
—
0
0
94
1042
0.89
0.46
1.5
1.7
1.4
1.4
%
0.11
81
908
7
50
1.40
0.45
1.4
2.1
—
—
—
0
0
24
296
0.81
0.44
1.1
1.3
40.9
38.4
g/l
1.12
16
248
11
78
1.41
0.43
1.5
1.3
—
—
—
0
0
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
24
194
1.24
0.42
2.0
1.5
—
—
—
0
0
8
57
1.41
0.42
1.1
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
0.6
—
0
11
5
34
1.47
0.40
1.6
1.4
7.8
9.2
ug/l
—
5
34
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
11
80
1.38
0.38
2.6
2.1
—
—
—
0
0
9
66
1.37
0.38
1.3
1.2
—
—
—
0
0
9
66
1.37
0.38
1.3
1.2
—
—
—
0
0
9
67
1.35
0.38
1.6
1.3
—
—
—
0
0
148
1383
1.08
0.36
2.8
2.6
2.3
3.7
e6/l
1.23
83
709
12
157
0.76
0.36
1.8
1.6
—
—
—
0
0
23
276
0.83
0.34
6.5
3.7
4.0
3.8
mmol/l
0.49
23
260
12
91
1.32
0.34
1.2
1.5
1.4
1.3
nmol/l
0.05
12
78
6
47
1.28
0.32
1.2
1.0
—
—
—
0
0
6
47
1.28
0.32
2.5
2.2
—
164.4
—
0
9
58
522
1.12
0.32
1.0
1.0
—
—
—
0
0
7
96
0.73
0.31
1.6
1.1
—
74.2
—
0
11
929
9181
1.05
0.29
15.2
12.9
39.7
39.4
%
0.52
624
6456
35
398
0.88
0.29
3.8
3.1
24.7
24.3
mmol/l
0.30
30
352
17
139
1.23
0.29
1.7
1.3
—
—
—
0
0
8
62
1.29
0.28
1.8
1.2
—
—
—
0
0
8
62
1.29
0.28
1.8
1.2
—
—
—
0
0
8
62
1.29
0.28
1.8
1.2
—
—
—
0
0
8
64
1.25
0.27
1.3
1.3
—
—
—
0
0
11
86
1.28
0.26
4.6
3.3
—
—
—
0
0
204
1956
1.05
0.25
1.8
1.7
1115.3
1201.4
nmol/l
0.71
154
1454
9
74
1.22
0.25
1.1
1.1
—
—
—
0
0
18
151
1.19
0.25
1.3
1.1
—
—
—
0
0
18
151
1.19
0.25
1.0
1.0
1.5
2.3
u/ml
—
8
64
17
142
1.20
0.24
1.3
1.2
299.7
228.0
u/ml
—
9
82
17
142
1.20
0.24
1.1
1.4
6.6
7.6
mmol/l
—
10
98
138
1312
1.06
0.23
6.9
6.4
—
—
—
0
0
5
39
1.28
0.23
1.0
1.2
30.2
29.6
umol/l
—
5
39
19
221
0.86
0.22
1.4
1.5
—
—
—
0
0
7
95
0.74
0.22
1.6
1.1
—
78.3
—
0
6
5
41
1.22
0.22
1.2
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
0.0
—
0
6
8
101
0.79
0.21
1.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
22
192
1.15
0.20
1.8
1.6
—
—
—
0
0
6
50
1.20
0.19
1.2
1.3
—
—
—
0
0
6
50
1.20
0.19
1.0
1.3
—
—
—
0
0
159
1529
1.05
0.19
2.7
2.5
0.9
1.5
e6/l
1.25
94
855
28
310
0.90
0.17
1.4
1.4
0.3
0.3
g/l
0.10
18
273
80
757
1.06
0.17
3.1
2.2
68.7
68.3
ml/min/173m2
0.03
39
313
5
66
0.76
0.17
1.0
1.2
—
—
—
0
0
43
398
1.08
0.16
1.3
1.7
—
—
—
0
0
12
141
0.85
0.16
1.2
1.5
—
—
—
0
0
18
158
1.14
0.16
1.4
1.5
—
—
—
0
0
14
162
0.86
0.16
2.6
2.6
32.7
34.5
umol/l
0.16
14
143
8
72
1.11
0.16
1.0
1.6
10.3
13.0
umol/l
—
8
67
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
6
78
0.77
0.15
2.5
1.5
—
—
—
0
0
101
967
1.05
0.15
2.0
2.0
9.3
6.4
umol/l
0.48
86
834
11
129
0.85
0.14
1.0
1.0
—
—
—
0
0
23
253
0.91
0.13
2.2
2.3
30.5
98.2
ug/min
1.59
12
156
85
815
1.05
0.13
3.8
3.0
115.3
180.6
ng/l
2.94
78
745
29
312
0.93
0.11
1.2
1.1
—
—
—
0
0
36
383
0.94
0.11
2.4
1.4
—
—
—
0
0
36
383
0.94
0.11
2.4
1.4
7.7
7.5
g/l
0.21
22
280
36
383
0.94
0.11
2.4
1.4
3.8
3.8
g/l
0.01
21
266
21
192
1.10
0.11
1.7
1.9
135.0
131.3
g/l
0.30
16
142
29
311
0.93
0.10
1.2
1.1
—
—
—
0
0
438
4329
1.02
0.10
2.0
2.0
102.3
97.3
pmol/l
1.10
220
2082
33
351
0.94
0.10
1.4
1.5
—
—
—
0
0
5
44
1.14
0.10
2.2
2.0
44.9
202.0
ug/l
—
5
38
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
5
45
1.11
0.10
1.4
5.1
—
89.1
—
0
9
34
360
0.94
0.09
2.2
1.7
1.5
1.5
g/l
0.03
29
315
34
356
0.95
0.06
2.5
1.4
2.7
3.0
g/l
1.23
22
273
23
244
0.94
0.06
1.4
1.4
448.4
1069.4
e6/l
0.56
23
206
27
284
0.95
0.06
1.3
1.4
—
—
—
0
0
19
178
1.07
0.05
1.2
1.1
0.1
1.3
u/ml
—
9
68
26
247
1.05
0.05
1.4
1.3
—
—
—
0
0
18
169
1.07
0.05
1.0
1.1
88.6
145.9
iu/ml
—
9
32
26
248
1.05
0.05
1.4
1.7
15334.7
11793.4
e6/l
0.22
17
188
31
298
1.04
0.04
1.3
1.2
36.2
2.6
u/ml
—
5
33
34
352
0.96
0.04
2.5
1.4
9.3
10.4
g/l
0.57
23
298
82
835
0.98
0.04
2.0
1.7
—
—
—
0
0
12
111
1.08
0.04
1.0
1.1
—
—
—
0
0
15
141
1.06
0.03
1.2
1.2
11.7
6.9
u/ml
—
6
55
16
169
0.95
0.03
1.7
1.7
—
—
—
0
0
49
501
0.98
0.03
1.4
1.8
—
—
—
0
0
13
138
0.94
0.02
1.1
1.1
—
—
—
0
0
33
321
1.03
0.02
1.6
1.7
—
—
—
0
0
229
2278
1.01
0.02
4.8
4.1
1.0
1.0
kg/l
0.04
46
335
15
143
1.05
0.01
1.2
1.2
10.2
1.6
u/ml
—
5
37
31
304
1.02
0.00
1.3
1.2
3.4
7.7
u/ml
—
6
60
13
134
0.97
0.00
1.2
1.1
—
—
—
0
0
28
276
1.01
0.00
1.2
1.3
489.2
485.4
mg/l
0.03
28
261
33
326
1.01
0.00
5.0
3.4
1.3
1.4
mmol/l
0.13
33
318
12
117
1.03
0.00
1.0
1.1
—
—
—
0
0
32
317
1.01
0.00
1.9
1.8
—
—
—
0
0
41
407
1.01
0.00
1.3
1.8
2.0
4.0
mg/l
0.69
22
281
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
7
73
0.96
0.00
1.1
1.1
269.3
245.9
mg/l
—
7
63
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
86
860
1.00
0.00
2.3
2.4
4.9
7.2
ug/l
0.78
68
749
0
9
0.00
0.00
0.0
1.6
—
10.0
—
0
9
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_THYROID_EXALLC – Benign neoplasm of thyroid gland
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).